Belite Bio (BLTE) Accumulated Expenses (2021 - 2025)

Belite Bio's Accumulated Expenses history runs 5 years deep, the most recent figure standing at $9.6 million for Q4 2025.

• In Q4 2025, Accumulated Expenses rose 67.26% year-over-year to $9.6 million; the TTM figure through Dec 2025 stood at $9.6 million (up 67.26% YoY), while the FY2025 annual figure was $9.6 million, up 67.26% from the prior year.
• Accumulated Expenses was $9.6 million for Q4 2025 at Belite Bio, up from $5.8 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $9.6 million in Q4 2025 to a low of $56000.0 in Q4 2021.
• Historically, Accumulated Expenses has averaged $3.8 million across 5 years, with a median of $3.3 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Accumulated Expenses soared 770.42% in 2023, then surged 67.26% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $56000.0 in 2021, then jumped by 582.14% to $382000.0 in 2022, then jumped by 770.42% to $3.3 million in 2023, then surged by 73.26% to $5.8 million in 2024, then soared by 67.26% to $9.6 million in 2025.
• The last three Accumulated Expenses figures came in at $9.6 million (Q4 2025), $5.8 million (Q4 2024), and $3.3 million (Q4 2023), per Business Quant data.